J&J Unveils Restructuring Initiatives
Johnson & Johnson (J&J) has announced global restructuring initiatives designed to strengthen its position in the world’s health care industry. The company is taking steps to prioritize its
Novartis has signed an agreement to purchase Myricx Bio, a UK-based biotechnology company, in a transaction valued at up to $1.5bn.